Xinyou Zhang

Xinyou Zhang

Auto-generated profile, based on publicly available information

Xinyou Zhang

Department of Hematology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2017 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
JZJihao Zhou
Jihao Zhou
YYYushi Yao
Yushi Yao
QSQi Shen
Qi Shen
GLGuoqiang Li
Guoqiang Li
LHLina Hu
Lina Hu
XZXinyou Zhang
Xinyou Zhang

24 November 2020 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
JHJingsheng Hua
Jingsheng Hua
JZJian Zhang
Jian Zhang
XZXinyou Zhang
Xinyou Zhang
XWXiaoxia Wu
Xiaoxia Wu
Lili ZhouLili Zhou
Lili Zhou
HQHuiying Qiu
Huiying Qiu

13 November 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
JZJihao Zhou
Jihao Zhou
QSQi Shen
Qi Shen
HLHaiqing Lin
Haiqing Lin
LHLina Hu
Lina Hu
GLGuoqiang Li
Guoqiang Li
XZXinyou Zhang
Xinyou Zhang

10 February 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YYYushi Yao
Yushi Yao
LWLei Wang
Lei Wang
JZJihao Zhou
Jihao Zhou
XZXinyou Zhang
Xinyou Zhang
Acute graft-versus-host disease (aGVHD) remains a major obstacle against favorable clinical outcomes following allogeneic hematopoietic stem cell transplantation (allo-HSCT). T helper cells including Th17 play key roles in aGVHD pathogenesis. Donor regulatory T cell (Tregs) adoptive therapy reduces aGVHD without weakening graft-versus-leukemia effect (GVL) in both mouse and human, although the purification and ex vivo expansion of Tregs in clinical scenarios remain costly and technically demanding. Hypoxia-inducible factor 1 alpha (HIF-1α) is a key molecule switch that attenuates Treg but promotes Th17 development. However, whether pharmacological inhibition of HIF-1α reduces aGVHD via increasing Treg development and diminishing Th17 responses remains unexplored. By using alloantigen-specific mixed lymphocyte culture and murine models of aGVHD and GVL, we evaluated the impacts of HIF-1α inhibition by echinomycin on the alloantigen-specific CD4 T cell responses ex vivo, as well as on aGVHD and GVL effect following allo-HSCT. Ex vivo echinomycin treatment resulted in increased number of Tregs in the culture as well as reduced alloantigen-specific Th17 and Th1 responses. In vivo echinomycin treatment reduced GVHD scores and prolonged survival of mice following allo-HSCT, which is associated with increased number of donor Tregs and reduced number of Th17 and Th1 in lymphoid tissues. In murine model of leukemia, echinomycin treatment preserved GVL effect and prolonged leukemia free survival following allo-HSCT. Echinomycin treatment reduces aGVHD and preserves GVL effect via increasing donor Treg development and diminishing alloantigen-specific Th17 and Th1 responses following allo-HSCT, presumably via direct inhibition of HIF-1α that results in preferential Treg differentiation during alloantigen-specific CD4 T cell responses. These findings highlight pharmacological inhibition of HIF-1α as a promising strategy in GVHD prophylaxis.

31 March 2020 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
PCPing Cai
Ping Cai
QWQian Wu
Qian Wu
YWYemin Wang
Yemin Wang
XYXiaofei Yang
Xiaofei Yang
XZXinyou Zhang
Xinyou Zhang
SCSuning Chen
Suning Chen
The Sanz risk, which was originally used to predict the risk of acute promyelocytic leukemia (APL) relapse, is a recognized method to predict the prognosis of APL. About 570 de novo APL patients admitted to our center were randomly divided into a training cohort (N = 344) and validation cohort (N = 226). Multivariate analysis of training cohort demonstrated that age >52 (OR = 5.170, p = .002), white blood cell count >10 × 109/L (OR = 9.062, p < .001), PLT count ≤10 × 109/L (OR = 4.254, p < .001), and LDH level >500 U/L (OR= 3.002, p = .046) were independent risk factors for early death. A risk score (age >52: 1.5 points; WBC >10 × 109/L: 2 points; PLT ≤10 × 109/L: 1 point; LDH >500 U/L: 1 point) was used to predict early death risk. The model shows a better predictive power of early death in training cohort and validation cohort compared with Sanz risk stratification.

1 January 2017 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
JZJ. Zhou
J. Zhou
YZY. Zhou
Y. Zhou
JWJ. Wen
J. Wen
XSX. Sun
X. Sun
XZX. Zhang
X. Zhang
Immune thrombocytopenia (ITP) is a disease characterized by isolated thrombocytopenia. Abnormal effector T cell activation is an important mechanism in the pathogenesis of ITP. Regulatory T cells (Treg) have a strong immunosuppressive function for T cell activation and their importance in the pathophysiology and clinical treatment of ITP has been confirmed. Myeloid-derived suppressor cells (MDSCs) are other immunosuppressive cells, which can also suppress T cell activation by secreting arginase, iNOS and ROS, and are essential for Treg cells’ differentiation and maturation. Therefore, we speculate that MDSCs might also be involved in the immune-dysregulation mechanism of ITP. In this study, we tested MDSCs and Treg cells in peripheral blood samples of twenty-five ITP patients and ten healthy donors. We found that MDSCs and Treg cells decreased simultaneously in active ITP patients. Relapsed ITP patients showed lower MDSCs levels compared with new patients. All patients received immunosuppressive treatment including dexamethasone alone or in combination with intravenous immune globulin. We found that MDSCs’ level after treatment correlated with platelet recovery. Our study is the first that focused on MDSCs’ role in ITP. Based on our results, we concluded that circulating MDSCs could predict disease activity and treatment response in ITP patients. This preliminary conclusion indicates a substantial significance of MDSCs in the pathophysiology and clinical treatment of ITP, which deserves further investigation.